The themes Thermo Fisher Scientific is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Доли выручки — это оценки за year ended December 31, 2025, а не цифры из поданной отчётности.
Thermo Scientific Orbitrap Tribrid Apex Mass Spectrometer
An instrument that measures molecules in samples to help researchers study complex biology, medicines, and other substances.
Thermo Scientific Vanquish Amplify ultra-high-performance liquid chromatography system
An instrument that separates and analyzes substances in liquid samples, including sensitive biological molecules.
Applied Biosystems PowerFlex Thermal Cycler
A laboratory instrument that repeatedly heats and cools samples to copy selected genetic material for testing or research.
DynaDrive single-use bioreactors
Containers and equipment used to grow cells and produce medicines; the single-use parts are replaced between production runs.
Diagnostic test kits and reagents
Tests and the chemicals needed to detect or monitor conditions such as allergies, thyroid disorders, infections, and drug levels.
PPD and Patheon services
PPD provides clinical research and clinical-trial services; Patheon develops and manufactures medicines for pharmaceutical and biotechnology customers.
Полная финансовая отчётность →
Thermo Fisher sells products and services to pharmaceutical and biotechnology companies, hospitals, clinical laboratories, universities, government agencies, and industrial customers. Its products include research supplies, instruments for analyzing samples, and diagnostic tests; its services include clinical-trial work and manufacturing medicines for customers. In the second quarter of 2026, management said customer demand had strengthened across its major markets.
Построено по собственной отчётности Thermo Fisher Scientific Inc., поданной в Комиссию по ценным бумагам и биржам США (SEC). Цифры — как отчиталась компания, история на акцию пересчитана на сегодняшнюю базу. Это описание бизнеса — не инвестиционная рекомендация и не совет что-либо покупать или продавать.
TMO · NYSE · Healthcare · Diagnostics and Research
699,56 $-2,5 %закрытие 12 нояб.
Данные по 26 сентября 2026 г., из отчёта 10-Q, поданного 30 октября 2026 г.
Thermo Fisher sells laboratory supplies, scientific instruments, diagnostic tests, and services for developing and making medicines.
Grade A+
Полоса под ценой показывает оценку на каждую дату — только по отчётам, которые к тому моменту уже были опубликованы.
Показано 2 из 41 кварталов истории оценок компании Thermo Fisher Scientific Inc.. Остальные 39 уходят к ноябрь 2016 г..